<PubmedArticle xmlns:ns0="http://www.w3.org/1998/Math/MathML"><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39391520</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>12</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2405-8440</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>19</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>15</Day></PubDate></JournalIssue><Title>Heliyon</Title><ISOAbbreviation>Heliyon</ISOAbbreviation></Journal><ArticleTitle>A vaccination-based COVID-19 model: Analysis and prediction using Hamiltonian Monte Carlo.</ArticleTitle><Pagination><StartPage>e38204</StartPage><MedlinePgn>e38204</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e38204</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.heliyon.2024.e38204</ELocationID><Abstract><AbstractText>Compartmental models have emerged as robust computational frameworks and have yielded remarkable success in the fight against COVID-19. This study proposes a vaccination-based compartmental model for COVID-19 transmission dynamics. The model reflects the specific stages of COVID-19 infection and integrates a vaccination strategy, allowing for a comprehensive analysis of how vaccination rates influence the disease spread. We fit this model to daily confirmed COVID-19 cases in Tennessee, United States of America (USA), from June 4 to November 26, 2021, in a Bayesian inference approach using the Hamiltonian Monte Carlo (HMC) algorithm. First, excluding vaccination dynamics from the model, we estimated key epidemiological parameters like infection, recovery, and disease-induced death rates. This analysis yielded a basic reproduction number ( <ns0:math> <ns0:msub><ns0:mrow><ns0:mi>R</ns0:mi></ns0:mrow> <ns0:mrow><ns0:mn>0</ns0:mn></ns0:mrow> </ns0:msub> </ns0:math> ) of 1.5. Second, we incorporated vaccination dynamics and estimated the vaccination rate for three vaccines: 0.0051 per day for both Pfizer and Moderna and 0.0059 per day for Janssen. The fitted curves show reductions in the epidemic peak for all three vaccines. Pfizer and Moderna vaccines bring the peak down from 8,029 infected cases to 5,616 infected cases, while the Janssen vaccine reduces it, to 6,493 infected cases. Simulations of the model by varying the vaccination rate and vaccine efficacy were performed. A highly effective vaccine (95% efficacy) with a daily vaccination rate of 0.006 halved COVID-19 infections, reducing cases from 8,029 to around 4,000. The results also show that the model's prediction accuracy for new observations improves with the number of observed data used to train the model.</AbstractText><CopyrightInformation>© 2024 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jdid</LastName><ForeName>Touria</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Laboratory of Engineering, Modeling and Systems Analysis (LIMAS), Faculty of Sciences, Sidi Mohamed Ben Abdellah University, Fez, Morocco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benbrahim</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory of Engineering, Modeling and Systems Analysis (LIMAS), Faculty of Sciences, Sidi Mohamed Ben Abdellah University, Fez, Morocco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kabbaj</LastName><ForeName>Mohammed Nabil</ForeName><Initials>MN</Initials><AffiliationInfo><Affiliation>Laboratory of Engineering, Modeling and Systems Analysis (LIMAS), Faculty of Sciences, Sidi Mohamed Ben Abdellah University, Fez, Morocco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naji</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory of Applied Physics Informatics and Statistics (LPAIS), Faculty of Sciences, Sidi Mohamed Ben Abdellah University, Fez, Morocco.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Heliyon</MedlineTA><NlmUniqueID>101672560</NlmUniqueID><ISSNLinking>2405-8440</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bayesian inference</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Epidemic models</Keyword><Keyword MajorTopicYN="N">Hamiltonian Monte Carlo</Keyword><Keyword MajorTopicYN="N">Prediction</Keyword><Keyword MajorTopicYN="N">Vaccination</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>4</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39391520</ArticleId><ArticleId IdType="pmc">PMC11466577</ArticleId><ArticleId IdType="doi">10.1016/j.heliyon.2024.e38204</ArticleId><ArticleId IdType="pii">S2405-8440(24)14235-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Shereen M.A., Khan S., Kazmi A., Bashir N., Siddique R. COVID-19 infection: emergence, transmission, and characteristics of human coronaviruses. J. Adv. Res. 2020;24:91–98. doi: 10.1016/j.jare.2020.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jare.2020.03.005</ArticleId><ArticleId IdType="pmc">PMC7113610</ArticleId><ArticleId IdType="pubmed">32257431</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge Y., Zhang W.-B., Liu H., Ruktanonchai C.W., Hu M., Wu X., Song Y., Ruktanonchai N.W., Yan W., Cleary E., Feng L., Li Z., Yang W., Liu M., Tatem A.J., Wang J.-F., Lai S. Impacts of worldwide individual non-pharmaceutical interventions on COVID-19 transmission across waves and space. Int. J. Appl. Earth Obs. Geoinf. 2022;106 doi: 10.1016/j.jag.2021.102649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jag.2021.102649</ArticleId><ArticleId IdType="pmc">PMC8666325</ArticleId><ArticleId IdType="pubmed">35110979</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Shabasy R.M., Nayel M.A., Taher M.M., Abdelmonem R., Shoueir K.R., Kenawy E.R. Three waves changes, new variant strains, and vaccination effect against COVID-19 pandemic. Int. J. Biol. Macromol. 2022;204:161–168. doi: 10.1016/j.ijbiomac.2022.01.118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2022.01.118</ArticleId><ArticleId IdType="pmc">PMC8782737</ArticleId><ArticleId IdType="pubmed">35074332</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO coronavirus (COVID-19) dashboard. May 2023. https://covid19.who.int</Citation></Reference><Reference><Citation>Peng L., Yang W., Zhang D., Zhuge C., Hong L. Epidemic analysis of COVID-19 in China by dynamical modeling. 2020. https://doi.org/10.48550/arXiv.2002.06563</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.2002.06563</ArticleId></ArticleIdList></Reference><Reference><Citation>Gumel A.B., Iboi E.A., Ngonghala C.N., Elbasha E.H. A primer on using mathematics to understand COVID-19 dynamics: modeling, analysis and simulations. Infect. Dis. Model. 2021;6:148–168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7786036</ArticleId><ArticleId IdType="pubmed">33474518</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittaker D.G., Herrera-Reyes A.D., Hendrix M., Owen M.R., Band L.R., Mirams G.R., Bolton K.J., Preston S.P. Uncertainty and error in SARS-CoV-2 epidemiological parameters inferred from population-level epidemic models. J. Theor. Biol. 2023;558 doi: 10.1016/j.jtbi.2022.111337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtbi.2022.111337</ArticleId><ArticleId IdType="pmc">PMC9637393</ArticleId><ArticleId IdType="pubmed">36351493</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajiya V.P., Bugalia S., Tripathi J.P. Mathematical modeling of COVID-19: Impact of non-pharmaceutical interventions in India. Chaos, Interdiscip. J. Nonlinear Sci. 2020;30 doi: 10.1063/5.0021353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1063/5.0021353</ArticleId><ArticleId IdType="pubmed">33261327</ArticleId></ArticleIdList></Reference><Reference><Citation>Panovska-Griffiths J., Kerr C.C., Stuart R.M., Mistry D., Klein D.J., Viner R.M., Bonell C. Determining the optimal strategy for reopening schools, the impact of test and trace interventions, and the risk of occurrence of a second COVID-19 epidemic wave in the UK: a modelling study. Lancet Child Adolesc. Health. 2020;4:817–827. doi: 10.1016/S2352-4642(20)30250-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(20)30250-9</ArticleId><ArticleId IdType="pmc">PMC7398659</ArticleId><ArticleId IdType="pubmed">32758453</ArticleId></ArticleIdList></Reference><Reference><Citation>Manevski D., Ružić Gorenjec N., Kejžar N., Blagus R. Modeling COVID-19 pandemic using Bayesian analysis with application to Slovene data. Math. Biosci. 2020;329 doi: 10.1016/j.mbs.2020.108466.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mbs.2020.108466</ArticleId><ArticleId IdType="pmc">PMC7482592</ArticleId><ArticleId IdType="pubmed">32920095</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y., Xu S., An Q., Qin M., Li S., Lu K., Li J., Lei L., He L., Yu H., Xie J. Coronavirus disease 2019 epidemic prediction in Shanghai under the “dynamic zero-COVID policy” using time-dependent SEAIQR model. J. Biosaf. Biosecurity. 2022;4:105–113. doi: 10.1016/j.jobb.2022.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jobb.2022.06.002</ArticleId><ArticleId IdType="pmc">PMC9212988</ArticleId><ArticleId IdType="pubmed">35756701</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R., Song Y., Qu H., Li M., Jiang G.-P. A data-driven epidemic model with human mobility and vaccination protection for COVID-19 prediction. J. Biomed. Inform. 2024;149 doi: 10.1016/j.jbi.2023.104571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2023.104571</ArticleId><ArticleId IdType="pubmed">38092247</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou T., Ji Y. Semiparametric Bayesian inference for the transmission dynamics of COVID-19 with a state-space model. Contemp. Clin. Trials. 2020;97 doi: 10.1016/j.cct.2020.106146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cct.2020.106146</ArticleId><ArticleId IdType="pmc">PMC7491370</ArticleId><ArticleId IdType="pubmed">32947047</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T., Wang Q., Leng Z., Yang Y., Yang J., Chen F., Jia M., Zhang X., Qi W., Xu Y., Chen S., Dai P., Ma L., Feng L., Yang W. A scenario-based evaluation of COVID-19-related essential clinical resource demands in China. Engineering. 2021;7:948–957. doi: 10.1016/j.eng.2021.03.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eng.2021.03.020</ArticleId><ArticleId IdType="pmc">PMC8137347</ArticleId><ArticleId IdType="pubmed">34035977</ArticleId></ArticleIdList></Reference><Reference><Citation>Rainisch G., Undurraga E.A., Chowell G. A dynamic modeling tool for estimating healthcare demand from the COVID19 epidemic and evaluating population-wide interventions. Int. J. Infect. Dis. 2020;96:376–383. doi: 10.1016/j.ijid.2020.05.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.05.043</ArticleId><ArticleId IdType="pmc">PMC7229979</ArticleId><ArticleId IdType="pubmed">32425631</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrido J.M., Martínez-Rodríguez D., Rodríguez-Serrano F., Pérez-Villares J.M., Ferreiro-Marzal A., Jiménez-Quintana M.M., Villanueva R.J. Mathematical model optimized for prediction and health care planning for COVID-19. Med. Intensiva (English Ed.) 2022;46:248–258. doi: 10.1016/j.medine.2022.02.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medine.2022.02.020</ArticleId><ArticleId IdType="pmc">PMC8882409</ArticleId><ArticleId IdType="pubmed">35256322</ArticleId></ArticleIdList></Reference><Reference><Citation>Acuña-Zegarra M.A., Díaz-Infante S., Baca-Carrasco D., Olmos-Liceaga D. COVID-19 optimal vaccination policies: a modeling study on efficacy, natural and vaccine-induced immunity responses. Math. Biosci. 2021;337 doi: 10.1016/j.mbs.2021.108614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mbs.2021.108614</ArticleId><ArticleId IdType="pmc">PMC8095066</ArticleId><ArticleId IdType="pubmed">33961878</ArticleId></ArticleIdList></Reference><Reference><Citation>Iboi E.A., Ngonghala C.N., Gumel A.B. Will an imperfect vaccine curtail the COVID-19 pandemic in the U.S.? Infect. Dis. Model. 2020;5:510–524. doi: 10.1016/j.idm.2020.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idm.2020.07.006</ArticleId><ArticleId IdType="pmc">PMC7409819</ArticleId><ArticleId IdType="pubmed">32835142</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen M., Zu J., Fairley C.K., Pagán J.A., An L., Du Z., Guo Y., Rong L., Xiao Y., Zhuang G., Li Y., Zhang L. Projected COVID-19 epidemic in the United States in the context of the effectiveness of a potential vaccine and implications for social distancing and face mask use. Vaccine. 2021;39:2295–2302. doi: 10.1016/j.vaccine.2021.02.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2021.02.056</ArticleId><ArticleId IdType="pmc">PMC7914016</ArticleId><ArticleId IdType="pubmed">33771391</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies N.G., Klepac P., Liu Y., Prem K., Jit M., Eggo R.M. Age-dependent effects in the transmission and control of COVID-19 epidemics. Nat. Med. 2020;26:1205–1211. doi: 10.1038/s41591-020-0962-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0962-9</ArticleId><ArticleId IdType="pubmed">32546824</ArticleId></ArticleIdList></Reference><Reference><Citation>Inward R.P.D., Jackson F., Dasgupta A., Lee G., Battle A.L., Parag K.V., Kraemer M.U.G. Impact of spatiotemporal heterogeneity in COVID-19 disease surveillance on epidemiological parameters and case growth rates. Epidemics. 2022;41 doi: 10.1016/j.epidem.2022.100627.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.epidem.2022.100627</ArticleId><ArticleId IdType="pmc">PMC9443927</ArticleId><ArticleId IdType="pubmed">36099708</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W., Zhang D., Peng L., Zhuge C., Hong L. Rational evaluation of various epidemic models based on the COVID-19 data of China. Epidemics. 2021;37 doi: 10.1016/j.epidem.2021.100501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.epidem.2021.100501</ArticleId><ArticleId IdType="pmc">PMC8464399</ArticleId><ArticleId IdType="pubmed">34601321</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu H., Xiong S., Zhang X., Liu S., Gu L., Zhu Y., Xiang D., Skitmore M. The COVID-19 pandemic in various restriction policy scenarios based on the dynamic social contact rate. Heliyon. 2023;9 doi: 10.1016/j.heliyon.2023.e14533.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2023.e14533</ArticleId><ArticleId IdType="pmc">PMC10017169</ArticleId><ArticleId IdType="pubmed">36945346</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiem C.T., Massonnaud C.R., Levy-Bruhl D., Poletto C., Colizza V., Bosetti P., Fontanet A., Gabet A., Olié V., Zanetti L., Boëlle P.-Y., Crépey P., Cauchemez S. A modelling study investigating short and medium-term challenges for COVID-19 vaccination: from prioritisation to the relaxation of measures. eClinicalMedicine. 2021;38 doi: 10.1016/j.eclinm.2021.101001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101001</ArticleId><ArticleId IdType="pmc">PMC8278244</ArticleId><ArticleId IdType="pubmed">34278284</ArticleId></ArticleIdList></Reference><Reference><Citation>Kermack W., McKendrick A. A contribution to the mathematical theory of epidemics. Proc. R. Soc. Lond. Ser. A. 1927;115(772):700–721.</Citation></Reference><Reference><Citation>Li M.Y., Graef J.R., Wang L., Karsai J. Global dynamics of a SEIR model with varying total population size. Math. Biosci. 1999;160:191–213. doi: 10.1016/S0025-5564(99)00030-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0025-5564(99)00030-9</ArticleId><ArticleId IdType="pubmed">10472754</ArticleId></ArticleIdList></Reference><Reference><Citation>Biala T.A., Khaliq A.Q.M. A fractional-order compartmental model for the spread of the COVID-19 pandemic. Commun. Nonlinear Sci. Numer. Simul. 2021;98 doi: 10.1016/j.cnsns.2021.105764.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cnsns.2021.105764</ArticleId><ArticleId IdType="pmc">PMC7959886</ArticleId><ArticleId IdType="pubmed">33746459</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C., Wang J. Modeling the transmission of COVID-19 in the US – a case study. Infect. Dis. Model. 2021;6:195–211. doi: 10.1016/j.idm.2020.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idm.2020.12.006</ArticleId><ArticleId IdType="pmc">PMC7809398</ArticleId><ArticleId IdType="pubmed">33506152</ArticleId></ArticleIdList></Reference><Reference><Citation>Omame A., Abbas M. Modeling SARS-CoV-2 and HBV co-dynamics with optimal control. Phys. A, Stat. Mech. Appl. 2023;615 doi: 10.1016/j.physa.2023.128607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.physa.2023.128607</ArticleId><ArticleId IdType="pmc">PMC9984188</ArticleId><ArticleId IdType="pubmed">36908694</ArticleId></ArticleIdList></Reference><Reference><Citation>Okuonghae D., Omame A. Analysis of a mathematical model for COVID-19 population dynamics in Lagos, Nigeria. Chaos Solitons Fractals. 2020;139 doi: 10.1016/j.chaos.2020.110032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chaos.2020.110032</ArticleId><ArticleId IdType="pmc">PMC7305939</ArticleId><ArticleId IdType="pubmed">32834593</ArticleId></ArticleIdList></Reference><Reference><Citation>Omame A., Sene N., Nometa I., Nwakanma C.I., Nwafor E.U., Iheonu N.O., Okuonghae D. Analysis of COVID-19 and comorbidity co-infection model with optimal control. Optim. Control Appl. Methods. 2021;42:1568–1590. doi: 10.1002/oca.2748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/oca.2748</ArticleId><ArticleId IdType="pmc">PMC8242909</ArticleId><ArticleId IdType="pubmed">34226774</ArticleId></ArticleIdList></Reference><Reference><Citation>Akuno A.O., Ramírez-Ramírez L.L., Espinoza J.F. Inference on a multi-patch epidemic model with partial mobility, residency, and demography: case of the 2020 COVID-19 outbreak in Hermosillo, Mexico. Entropy. 2023;25:968. doi: 10.3390/e25070968.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/e25070968</ArticleId><ArticleId IdType="pmc">PMC10378648</ArticleId><ArticleId IdType="pubmed">37509915</ArticleId></ArticleIdList></Reference><Reference><Citation>Omame A., Okuonghae D., Nwajeri U.K., Onyenegecha C.P. A fractional-order multi-vaccination model for COVID-19 with non-singular kernel. Alex. Eng. J. 2022;61:6089–6104. doi: 10.1016/j.aej.2021.11.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aej.2021.11.037</ArticleId></ArticleIdList></Reference><Reference><Citation>Randolph H.E., Barreiro L.B. Herd immunity: understanding COVID-19. Immunity. 2020;52:737–741. doi: 10.1016/j.immuni.2020.04.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.04.012</ArticleId><ArticleId IdType="pmc">PMC7236739</ArticleId><ArticleId IdType="pubmed">32433946</ArticleId></ArticleIdList></Reference><Reference><Citation>MacIntyre C.R., Costantino V., Trent M. Modelling of COVID-19 vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, Australia. Vaccine. 2022;40:2506–2513. doi: 10.1016/j.vaccine.2021.04.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2021.04.042</ArticleId><ArticleId IdType="pmc">PMC8064825</ArticleId><ArticleId IdType="pubmed">33958223</ArticleId></ArticleIdList></Reference><Reference><Citation>Parolini N., Dede' L., Ardenghi G., Quarteroni A. Modelling the COVID-19 epidemic and the vaccination campaign in Italy by the SUIHTER model. Infect. Dis. Model. 2022;7:45–63. doi: 10.1016/j.idm.2022.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idm.2022.03.002</ArticleId><ArticleId IdType="pmc">PMC8906164</ArticleId><ArticleId IdType="pubmed">35284699</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P., Wu K., Ghattas O. Bayesian inference of heterogeneous epidemic models: application to COVID-19 spread accounting for long-term care facilities. Comput. Methods Appl. Mech. Eng. 2021;385 doi: 10.1016/j.cma.2021.114020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cma.2021.114020</ArticleId><ArticleId IdType="pmc">PMC8253717</ArticleId><ArticleId IdType="pubmed">34248229</ArticleId></ArticleIdList></Reference><Reference><Citation>Betancourt M. A conceptual introduction to Hamiltonian Monte Carlo. 2018. https://doi.org/10.48550/arXiv.1701.02434</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.1701.02434</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade J., Duggan J. An evaluation of Hamiltonian Monte Carlo performance to calibrate age-structured compartmental SEIR models to incidence data. Epidemics. 2020;33 doi: 10.1016/j.epidem.2020.100415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.epidem.2020.100415</ArticleId><ArticleId IdType="pubmed">33212347</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyaniwura S.A., Falcão R.C., Ringa N., Adu P.A., Spencer M., Taylor M., Colijn C., Coombs D., Janjua N.Z., Irvine M.A., Otterstatter M. Mathematical modeling of COVID-19 in British Columbia: an age-structured model with time-dependent contact rates. Epidemics. 2022;39 doi: 10.1016/j.epidem.2022.100559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.epidem.2022.100559</ArticleId><ArticleId IdType="pmc">PMC8993502</ArticleId><ArticleId IdType="pubmed">35447505</ArticleId></ArticleIdList></Reference><Reference><Citation>Grinsztajn L., Semenova E., Margossian C.C., Riou J. Bayesian workflow for disease transmission modeling in Stan. Stat. Med. 2021;40:6209–6234. doi: 10.1002/sim.9164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.9164</ArticleId><ArticleId IdType="pmc">PMC8661657</ArticleId><ArticleId IdType="pubmed">34494686</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatzilena A., van Leeuwen E., Ratmann O., Baguelin M., Demiris N. Contemporary statistical inference for infectious disease models using Stan. Epidemics. 2019;29 doi: 10.1016/j.epidem.2019.100367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.epidem.2019.100367</ArticleId><ArticleId IdType="pubmed">31591003</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., Guan X., Wu P., Wang X., Zhou L., Tong Y., Ren R., Leung K.S., Lau E.H., Wong J.Y., Xing X., Xiang N., Wu Y., Li C., Chen Q., Li D., Liu T., Zhao J., Liu M., Tu W., Chen C., Jin L., Yang R., Wang Q., Zhou S., Wang R., Liu H., Luo Y., Liu Y., Shao G., Li H., Tao Z., Yang Y., Deng Z., Liu B., Ma Z., Zhang Y., Shi G., Lam T.T., Wu J.T., Gao G.F., Cowling B.J., Yang B., Leung G.M., Feng Z. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N. Engl. J. Med. 2020;382:1199–1207. doi: 10.1056/NEJMoa2001316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001316</ArticleId><ArticleId IdType="pmc">PMC7121484</ArticleId><ArticleId IdType="pubmed">31995857</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauer S.A., Grantz K.H., Bi Q., Jones F.K., Zheng Q., Meredith H.R., Azman A.S., Reich N.G., Lessler J. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann. Intern. Med. 2020;172:577–582. doi: 10.7326/M20-0504.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-0504</ArticleId><ArticleId IdType="pmc">PMC7081172</ArticleId><ArticleId IdType="pubmed">32150748</ArticleId></ArticleIdList></Reference><Reference><Citation>Linton N.M., Kobayashi T., Yang Y., Hayashi K., Akhmetzhanov A.R., Jung S.-m., Yuan B., Kinoshita R., Nishiura H. Incubation period and other epidemiological characteristics of 2019 novel coronavirus infections with right truncation: a statistical analysis of publicly available case data. J. Clin. Med. 2020;9:538. doi: 10.3390/jcm9020538.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9020538</ArticleId><ArticleId IdType="pmc">PMC7074197</ArticleId><ArticleId IdType="pubmed">32079150</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizumoto K., Kagaya K., Zarebski A., Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro Surveill. 2020;25 doi: 10.2807/1560-7917.ES.2020.25.10.2000180.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2020.25.10.2000180</ArticleId><ArticleId IdType="pmc">PMC7078829</ArticleId><ArticleId IdType="pubmed">32183930</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravindra K., Malik V.S., Padhi B.K., Goel S., Gupta M. Asymptomatic infection and transmission of COVID-19 among clusters: systematic review and meta-analysis. Publ. Health. 2022;203:100–109. doi: 10.1016/j.puhe.2021.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.puhe.2021.12.003</ArticleId><ArticleId IdType="pmc">PMC8654597</ArticleId><ArticleId IdType="pubmed">35038628</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiura H., Kobayashi T., Miyama T., Suzuki A., Jung S.-m., Hayashi K., Kinoshita R., Yang Y., Yuan B., Akhmetzhanov A.R., Linton N.M. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19) Int. J. Infect. Dis. 2020;94:154–155. doi: 10.1016/j.ijid.2020.03.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.03.020</ArticleId><ArticleId IdType="pmc">PMC7270890</ArticleId><ArticleId IdType="pubmed">32179137</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou L., Ruan F., Huang M., Liang L., Huang H., Hong Z., Yu J., Kang M., Song Y., Xia J., Guo Q., Song T., He J., Yen H.-L., Peiris M., Wu J. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N. Engl. J. Med. 2020;382:1177–1179. doi: 10.1056/NEJMc2001737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2001737</ArticleId><ArticleId IdType="pmc">PMC7121626</ArticleId><ArticleId IdType="pubmed">32074444</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledford H. Coronavirus reinfections: three questions scientists are asking. Nature. 2020;585:168–169. doi: 10.1038/d41586-020-02506-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-020-02506-y</ArticleId><ArticleId IdType="pubmed">32887957</ArticleId></ArticleIdList></Reference><Reference><Citation>Thieme H.R. 2018. Mathematics in Population Biology.</Citation></Reference><Reference><Citation>CSSEGISandData COVID-19 data repository by the center for systems science and engineering (CSSE) at Johns Hopkins University. Jun. 2023. https://github.com/CSSEGISandData/COVID-19</Citation></Reference><Reference><Citation>Bureau U.C. Redistricting data program. Nov. 2022. https://www.census.gov/rdo</Citation></Reference><Reference><Citation>Anderson R.M., May R.M. Vaccination and herd immunity to infectious diseases. Nature. 1985;318:323–329. doi: 10.1038/318323a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/318323a0</ArticleId><ArticleId IdType="pubmed">3906406</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Driessche P., Watmough J. Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission. Math. Biosci. 2002;180:29–48. doi: 10.1016/S0025-5564(02)00108-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0025-5564(02)00108-6</ArticleId><ArticleId IdType="pubmed">12387915</ArticleId></ArticleIdList></Reference><Reference><Citation>Delamater P.L., Street E.J., Leslie T.F., Yang Y.T., Jacobsen K.H. Complexity of the basic reproduction number (R0) Emerg. Infect. Dis. 2019;25:1–4. doi: 10.3201/eid2501.171901.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2501.171901</ArticleId><ArticleId IdType="pmc">PMC6302597</ArticleId><ArticleId IdType="pubmed">30560777</ArticleId></ArticleIdList></Reference><Reference><Citation>Lye A., Cicirello A., Patelli E. Sampling methods for solving Bayesian model updating problems: a tutorial. Mech. Syst. Signal Process. 2021;159 doi: 10.1016/j.ymssp.2021.107760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymssp.2021.107760</ArticleId></ArticleIdList></Reference><Reference><Citation>Betancourt M., Stein L.C. The geometry of Hamiltonian Monte Carlo. 2011. https://doi.org/10.48550/arXiv.1112.4118</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.1112.4118</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman M.D., Gelman A. The no-u-turn sampler: adaptively setting path lengths in Hamiltonian Monte Carlo. J. Mach. Learn. Res. 2014;15:1593–1623.</Citation></Reference><Reference><Citation>Carpenter B., Gelman A., Hoffman M.D., Lee D., Goodrich B., Betancourt M., Brubaker M., Guo J., Li P., Riddell A. Stan: a probabilistic programming language. J. Stat. Softw. 2017;76 doi: 10.18637/jss.v076.i01.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v076.i01</ArticleId><ArticleId IdType="pmc">PMC9788645</ArticleId><ArticleId IdType="pubmed">36568334</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutiso F., Pearce J.L., Benjamin-Neelon S.E., Mueller N.T., Li H., Neelon B. Bayesian negative binomial regression with spatially varying dispersion: modeling COVID-19 incidence in Georgia. Spat. Stat. 2022;52 doi: 10.1016/j.spasta.2022.100703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.spasta.2022.100703</ArticleId><ArticleId IdType="pmc">PMC9500097</ArticleId><ArticleId IdType="pubmed">36168515</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelman A., Carlin J.B., Stern H.S., Rubin D.B. Chapman and Hall/CRC; 1995. Bayesian Data Analysis.</Citation><ArticleIdList><ArticleId IdType="doi">10.1201/9780429258411</ArticleId></ArticleIdList></Reference><Reference><Citation>Eikenberry S.E., Mancuso M., Iboi E., Phan T., Eikenberry K., Kuang Y., Kostelich E., Gumel A.B. To mask or not to mask: modeling the potential for face mask use by the general public to curtail the COVID-19 pandemic. Infect. Dis. Model. 2020;5:293–308. doi: 10.1016/j.idm.2020.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idm.2020.04.001</ArticleId><ArticleId IdType="pmc">PMC7186508</ArticleId><ArticleId IdType="pubmed">32355904</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R., Pei S., Chen B., Song Y., Zhang T., Yang W., Shaman J. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2) Science. 2020;368:489–493. doi: 10.1126/science.abb3221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb3221</ArticleId><ArticleId IdType="pmc">PMC7164387</ArticleId><ArticleId IdType="pubmed">32179701</ArticleId></ArticleIdList></Reference><Reference><Citation>Read J.M., Bridgen J.R.E., Cummings D.A.T., Ho A., Jewell C.P. Novel coronavirus 2019-nCoV (COVID-19): early estimation of epidemiological parameters and epidemic size estimates. Philos. Trans. R. Soc. Lond. B, Biol. Sci. 2021;376 doi: 10.1098/rstb.2020.0265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rstb.2020.0265</ArticleId><ArticleId IdType="pmc">PMC8165596</ArticleId><ArticleId IdType="pubmed">34053269</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang B., Wang X., Li Q., Bragazzi N.L., Tang S., Xiao Y., Wu J. Estimation of the transmission risk of the 2019-nCoV and its implication for public health interventions. J. Clin. Med. 2020;9:462. doi: 10.3390/jcm9020462.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9020462</ArticleId><ArticleId IdType="pmc">PMC7074281</ArticleId><ArticleId IdType="pubmed">32046137</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X., Guan L., Wei Y., Li H., Wu X., Xu J., Tu S., Zhang Y., Chen H., Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Senapati A., Rana S., Das T., Chattopadhyay J. Impact of intervention on the spread of COVID-19 in India: a model based study. J. Theor. Biol. 2021;523 doi: 10.1016/j.jtbi.2021.110711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtbi.2021.110711</ArticleId><ArticleId IdType="pmc">PMC8056976</ArticleId><ArticleId IdType="pubmed">33862090</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma S., Volpert V., Banerjee M. Extended SEIQR type model for COVID-19 epidemic and data analysis. Aug. 2020. https://doi.org/10.1101/2020.08.10.20171439</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.08.10.20171439</ArticleId><ArticleId IdType="pubmed">33378910</ArticleId></ArticleIdList></Reference><Reference><Citation>Puglisi L.B., Malloy G.S.P., Harvey T.D., Brandeau M.L., Wang E.A. Estimation of COVID-19 basic reproduction ratio in a large urban jail in the United States. Ann. Epidemiol. 2021;53:103–105. doi: 10.1016/j.annepidem.2020.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annepidem.2020.09.002</ArticleId><ArticleId IdType="pmc">PMC7480336</ArticleId><ArticleId IdType="pubmed">32919033</ArticleId></ArticleIdList></Reference><Reference><Citation>Team S.D. Stan user's guide. 2023. https://mc-stan.org/docs/stan-users-guide/</Citation></Reference><Reference><Citation>Vehtari A., Gelman A., Simpson D., Carpenter B., Bürkner P.-C. Rank-normalization, folding, and localization: an improved <ns0:math altimg="si155.svg"><ns0:mover accent="true"><ns0:mrow><ns0:mi mathvariant="normal">R</ns0:mi></ns0:mrow><ns0:mrow><ns0:mo stretchy="false">ˆ</ns0:mo></ns0:mrow></ns0:mover></ns0:math> for assessing convergence of MCMC (with discussion) Bayesian Anal. 2021;16:667–718. doi: 10.1214/20-BA1221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1214/20-BA1221</ArticleId></ArticleIdList></Reference><Reference><Citation>Grinsztajn L., Semenova E., Margossian C.C., Riou J. Bayesian workflow for disease transmission modeling in Stan. https://mc-stan.org/users/documentation/case-studies/boarding_school_case_study.html#fnref7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8661657</ArticleId><ArticleId IdType="pubmed">34494686</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.H., Marks F., Clemens J.D. Looking beyond COVID-19 vaccine phase 3 trials. Nat. Med. 2021;27:205–211. doi: 10.1038/s41591-021-01230-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01230-y</ArticleId><ArticleId IdType="pubmed">33469205</ArticleId></ArticleIdList></Reference><Reference><Citation>Food U.S., Administration D. FDA issues emergency use authorization for third COVID-19 vaccine. Feb. 2021. https://www.fda.gov/news-events/press-announcements/fda-issues-emergency-use-authorization-third-covid-19-vaccine</Citation></Reference><Reference><Citation>COVID-19 vaccine EUA recipient/caregiver fact sheets | CDC. Jun. 2022. https://www.cdc.gov/vaccines/covid-19/eua/index.html</Citation></Reference><Reference><Citation>T.D. of Health  Downloadable datasets. https://www.tn.gov/health/cedep/ncov/data/downloadable-datasets.html</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>